K052253 is an FDA 510(k) clearance for the MODIFICATION TO: DRYAC ACID CONCENTRATE MIX FOR BICARBONATE HEMODIALYSIS. This device is classified as a Dialysate Concentrate For Hemodialysis (liquid Or Powder) (Class II — Special Controls, product code KPO).
Submitted by Gambro Renal Products (Daytona Beach, US). The FDA issued a Cleared decision on November 2, 2005, 76 days after receiving the submission on August 18, 2005.
This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5820.
| 510(k) Number | K052253 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | August 18, 2005 |
| Decision Date | November 02, 2005 |
| Days to Decision | 76 days |
| Submission Type | Special |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
| Product Code | KPO — Dialysate Concentrate For Hemodialysis (liquid Or Powder) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 876.5820 |